Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announced today that its LEGION Hinged Knee (HK) ...

Smith & Nephew has announced it has revised plans to leave Hull after almost 170 years in the city, citing an increase in ...

Smith & Nephew (LSE:SN.) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights ...

Smith+Nephew (NYSE: SNN) announced today that it launched its Legion hinged knee (HK) system with Oxinium implant technology ...

The medical company announced in 2022 that it was leaving the city but now says it plans to operate in both Hull and Melton ...

Local leaders have expressed their delight at the company's revised plan to keep its Hull site open and build a new facility ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announced today that its LEGION Hinged Knee (HK) System is now available in the United States with proprietary OXINIUM ...

Smith & Nephew (LSE:SN.) is navigating a dynamic period marked by both opportunities and challenges. Recent highlights include a notable 31.2% increase in dividend payouts and innovative product ...

Smith & Nephew has announced it has revised plans to leave Hull after almost 170 years in the city, citing an increase in costs for the decision. In 2022, the global medical company announced it ...

First cases using Smith+Nephew’s new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility GlobeNewswire September 18, 2024 Smith+Nephew (LSE:SN, NYSE:SNN), ...